Aehr Test Systems (AEHR) has had the highest return this year by a mid-cap US stock, returning 384%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Aehr Test Systems (AEHR) | 2026 | 383.97% |
Erasca (ERAS) | 2026 | 375.2% |
Twist Bioscience (TWST) | 2026 | 358.84% |
AXT (AXTI) | 2026 | 311.28% |
10X Genomics (TXG) | 2026 | 299.26% |
Enliven Therapeutics (ELVN) | 2026 | 285.94% |
Immunitybio (IBRX) | 2026 | 285.64% |
MaxLinear (MXL) | 2026 | 273.58% |
Pulse Biosciences (PLSE) | 2026 | 264.57% |
Oruka Therapeutics (ORKA) | 2026 | 256.19% |
Sellas Life Sciences (SLS) | 2026 | 247.42% |
Definium Therapeutics (DFTX) | 2026 | 232.67% |
Abcellera Biologics (ABCL) | 2026 | 230.99% |
Spyre Therapeutics (SYRE) | 2026 | 225.06% |
Amylyx Pharmaceuticals (AMLX) | 2026 | 222.17% |
Ichor (ICHR) | 2026 | 213.71% |
Veradermics (MANE) | 2026 | 202.41% |
Hyperliquid Strategies Inc Common Stock (PURR) | 2026 | 199.72% |
Iovance Biotherapeutics (IOVA) | 2026 | 198.2% |
Ultra Clean (UCTT) | 2026 | 192.39% |
P3 Health Partners (PIII) | 2026 | 191.24% |
Maase (MAAS) | 2026 | 189.35% |
Iridium Communications (IRDM) | 2026 | 182.16% |
ChronoScale (CHRN) | 2026 | 178.89% |
Silicon Motion Technology (SIMO) | 2026 | 175.42% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.